Glycated Hemoglobin: Why HbA1c Remains One of the Most Important Biomarkers in Diabetes Care

Diabetes management has shifted from relying solely on individual blood glucose readings to evaluating long-term patterns of glycemic control. At the center of this approach is glycated hemoglobin (HbA1c), a laboratory marker that provides clinicians with an estimate of average blood glucose exposure over approximately the previous two to three months. Today, HbA1c plays a critical role in diagnosing diabetes, monitoring treatment effectiveness, and assessing the risk of long-term complications.

Unlike a fasting glucose measurement or a finger-stick test that captures blood sugar at a single moment, HbA1c reflects cumulative glucose exposure over the lifespan of red blood cells. This broader perspective makes it one of the most valuable biomarkers available in routine diabetes care.

What Is Glycated Hemoglobin?

Hemoglobin is the protein inside red blood cells responsible for carrying oxygen throughout the body. When glucose circulates in the bloodstream, a small portion naturally attaches to hemoglobin through a non-enzymatic process known as glycation.

Once glucose binds to hemoglobin, it remains attached for the life of the red blood cell, which averages about 120 days. The percentage of glycated hemoglobin—reported as HbA1c or simply A1C—therefore reflects the average concentration of blood glucose during the previous two to three months.

Higher average blood glucose leads to a higher HbA1c value.

Why HbA1c Matters

HbA1c provides clinicians with information that daily glucose measurements alone cannot offer.

Daily glucose values fluctuate based on meals, physical activity, stress, illness, medications, and sleep. HbA1c smooths out these short-term variations to reveal overall glycemic exposure.

Healthcare professionals use HbA1c to:

• Diagnose diabetes and prediabetes
• Evaluate long-term glucose management
• Assess whether treatment plans are effective
• Estimate the future risk of diabetes-related complications
• Guide medication adjustments alongside other clinical information

Because HbA1c represents long-term control, most diabetes organizations recommend periodic testing throughout the year for individuals living with diabetes, according to the ADA.

Understanding HbA1c Results

Current diagnostic thresholds are well established.

HbA1c (%)	Interpretation
Below 5.7%	Normal
5.7%–6.4%	Prediabetes
6.5% or higher	Diabetes (confirmation may be required)

These thresholds are based on evidence linking increasing HbA1c levels with the development of diabetic retinopathy and other complications. Laboratory testing used for diagnosis should be performed using NGSP-certified methods standardized to the landmark DCCT study.

For individuals already diagnosed with diabetes, treatment goals are individualized. While many nonpregnant adults aim for an HbA1c below 7%, age, comorbidities, hypoglycemia risk, and overall health all influence appropriate targets.

HbA1c and Average Glucose

One challenge for patients is translating an HbA1c percentage into something meaningful during everyday glucose monitoring.

Researchers developed the concept of estimated Average Glucose (eAG) to bridge this gap. eAG converts an HbA1c result into units commonly displayed on glucose meters or continuous glucose monitors (CGMs), making laboratory results easier to interpret.

For example:

HbA1c	Estimated Average Glucose
6.0%	~126 mg/dL
7.0%	~154 mg/dL
8.0%	~183 mg/dL
9.0%	~212 mg/dL

For patients or clinicians who want to translate HbA1c values into estimated average glucose—or perform the reverse calculation—a free online A1C Calculator can simplify these conversions during patient education or clinical discussions. The calculator follows the widely accepted ADAG conversion formula and presents results in both conventional and SI units, making interpretation easier alongside laboratory reports.

Recognizing the Limitations of HbA1c

Although HbA1c is extremely useful, it is not perfect.

Certain medical conditions can affect red blood cell lifespan or alter hemoglobin structure, producing results that do not accurately reflect average glucose.

Examples include:

• Iron deficiency anemia
• Hemolytic anemia
• Recent blood loss or transfusion
• Chronic kidney disease
• Pregnancy
• Certain hemoglobin variants, including sickle cell disease

In these situations, healthcare providers may rely more heavily on continuous glucose monitoring, self-monitoring of blood glucose, fructosamine testing, or other assessments to evaluate glycemic control.

HbA1c in Modern Diabetes Management

The widespread adoption of continuous glucose monitoring has transformed diabetes care, but HbA1c remains highly relevant.

CGMs provide valuable information about:

• Time in Range (TIR)
• Time Above Range
• Time Below Range
• Daily glucose variability

These metrics reveal patterns that HbA1c cannot capture. For example, two patients may have an identical HbA1c of 7%, yet one experiences frequent hypoglycemia while the other has consistently stable glucose.

Rather than replacing HbA1c, CGM data complements it. Together they provide a more complete picture of metabolic health and help clinicians individualize therapy.

Standardization Improves Reliability

One reason HbA1c has become such a trusted biomarker is the extensive international effort to standardize testing.

The National Glycohemoglobin Standardization Program (NGSP) ensures that certified laboratory methods remain traceable to the Diabetes Control and Complications Trial (DCCT), while the International Federation of Clinical Chemistry (IFCC) provides global reference standards. This consistency allows physicians to compare results across laboratories with confidence.

Looking Ahead

Researchers continue to explore new biomarkers, advanced CGM analytics, and precision medicine approaches for diabetes management. Despite these innovations, glycated hemoglobin remains one of the most clinically valuable laboratory measurements available.

Its ability to summarize long-term glucose exposure, support diagnosis, guide treatment decisions, and predict complication risk has made HbA1c an indispensable component of modern diabetes care.

As healthcare increasingly combines laboratory biomarkers with continuous glucose data and personalized treatment strategies, HbA1c will likely remain a cornerstone of diabetes management for years to come.

---

References

• American Diabetes Association. Standards of Care in Diabetes – Diagnosis and Classification of Diabetes. https://diabetesjournals.org/care/article/47/Supplement_1/S20/153954/2-Diagnosis-and-Classification-of-Diabetes
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The A1C Test. https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test-race-ethnicity
• National Glycohemoglobin Standardization Program (NGSP). IFCC Standardization of HbA1c. https://ngsp.org/ifccngsp.asp
• Hemoglobin A1C (HbA1c) Test: MedlinePlus Medical Test. https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/